Wegovy (Semaglutide) vs Mounjaro (Tirzepatide)

Wegovy (Semaglutide) vs Mounjaro (Tirzepatide)

Both Wegovy and Mounjaro, target adults with obesity or type 2 diabetes, but Mounjaro is also approved for weight management in the UK. Wegovy uses semaglutide to mimic GLP-1, a gut hormone that curbs appetite. Mounjaro uses tirzepatide to mimic both GLP-1 and GIP, another gut hormone that helps regulate blood sugar.

While both medications have side effects like nausea and require a high BMI for prescription, Mounjaro seems more effective for weight loss at higher doses. However, Mounjaro might be pricier and harder to find, especially in higher doses. Ultimately, consulting a doctor helps determine the best medication for your individual needs.

 

Original article posted here: https://www.thelondonobesityclinic.com/wegovy-semaglutide-vs-mounjaro-tirzepatide/

You may be interested in

How India is Redefining Wellness

How India is Redefining Wellness?

India is embracing a healthier lifestyle with a growing focus on wellness, driven by rising health awareness and the prevalence of non-communicable diseases. Ancient practices such as Ayurveda, yoga, and

Maximising Creatine's Performance Benefits

Maximising Creatine’s Performance Benefits

Creatine as an ergogenic aidCreatine is a widely used supplement that enhances sports performance by improving muscle concentration, exercise capacity, and training adaptation. Role in the bodySynthesised in the kidneys

Sign up for our Newsletter